Literature DB >> 7199426

Epidemiology of hepatic angiosarcoma in the United States: 1964-1974.

H Falk, J Herbert, S Crowley, K G Ishak, L B Thomas, H Popper, G G Caldwell.   

Abstract

A nationwide survey of hepatic angiosarcoma (HAS) in the United States during the years 1964 through 1974 identified 168 cases. Of these, 42 cases (25%) were associated with known etiologic factors, such as vinyl chloride monomer exposure during preparation of poly(vinyl chloride), use of Thorotrast in angiography, exposure to inorganic arsenic, and treatment with androgenic-anabolic steroids; 126 cases (75%) are of uncertain etiology. HAS most often affects males (ratio of approximately 3:1), peaks in the sixth and seventh decades of life (somewhat earlier than other sarcomas of the liver) and appears to occur more often in the industrialized Northeast and Midwest (although reporting artifact may be a factor). There is an extraordinary relative risk for poly(vinyl chloride) polymerization workers; there may also be other chemical-industrial associations that require further investigation. Prospective epidemiologic studies of HAS should be considered as a means of identifying other causative factors (e.g., chemicals or drugs) related to HAS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199426      PMCID: PMC1568861          DOI: 10.1289/ehp.8141107

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  24 in total

1.  Thorotrast-induced cancer in man.

Authors:  R BASERGA; H YOKOO; G C HENEGAR
Journal:  Cancer       Date:  1960 Sep-Oct       Impact factor: 6.860

2.  [After-effects of chronic arsenism in Moselle wine makers].

Authors:  F ROTH
Journal:  Dtsch Med Wochenschr       Date:  1957-02-08       Impact factor: 0.628

3.  Neoplastic risk among workers exposed to vinyl chloride.

Authors:  R J Waxweiler; W Stringer; J K Wagoner; J Jones; H Falk; C Carter
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

4.  Thorium dioxide effects in man. Epidemiological, clinical, and pathological studies (experience in Portugal).

Authors:  J Da Silva Horta; C Da Motta; M H Tavares
Journal:  Environ Res       Date:  1974-10       Impact factor: 6.498

5.  Hemangioendothelial sarcoma of the liver and hemochromatosis.

Authors:  E B Sussman; I Nydick; G F Gray
Journal:  Arch Pathol       Date:  1974-01

6.  [Malignant hemangioma of the liver and chronic arsenicism].

Authors:  H Rennke; G Prat; R Etcheverry; R Katz; S Donoso
Journal:  Rev Med Chil       Date:  1971-09       Impact factor: 0.553

7.  Angiosarcoma of liver associated with phenelzine.

Authors:  T K Daneshmend; G L Scott; J W Bradfield
Journal:  Br Med J       Date:  1979-06-23

8.  Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain.

Authors:  P J Baxter; P P Anthony; R N Macsween; P J Scheuer
Journal:  Br J Ind Med       Date:  1980-08

Review 9.  The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.

Authors:  G Y Locker; J H Doroshow; L A Zwelling; B A Chabner
Journal:  Medicine (Baltimore)       Date:  1979-01       Impact factor: 1.889

10.  Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.

Authors:  H Popper; L B Thomas; N C Telles; H Falk; I J Selikoff
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

View more
  17 in total

Review 1.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

Review 2.  [Primary sarcomas and sarcoma metastases in the liver: morphological and molecular aspects].

Authors:  G Mechtersheimer; R Penzel; W J Hofmann; P Schirmacher
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

3.  Spontaneous rupture of a necrotic hepatic angiosarcoma: findings on dual-phase computed tomography and angiography.

Authors:  Koshi Ikeda; Minoru Maehara; Naoto Ohmura; Hiroaki Kurokawa; Kenji Koda; Hidetaro Yokoyama; Satoshi Sawada
Journal:  Radiat Med       Date:  2006-06

4.  Epidemiology of primary and secondary liver cancers.

Authors:  Ashwin Ananthakrishnan; Veena Gogineni; Kia Saeian
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

5.  Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model.

Authors:  Sonja Rothweiler; Michael T Dill; Luigi Terracciano; Zuzanna Makowska; Luca Quagliata; Ruslan Hlushchuk; Valentin Djonov; Markus H Heim; David Semela
Journal:  Lab Invest       Date:  2014-11-24       Impact factor: 5.662

Review 6.  Primary hepatic angiosarcoma: A report of two cases and literature review.

Authors:  Yi-Ping Zhu; Yan-Min Chen; Erik Matro; Ren-Biao Chen; Zhi-Nong Jiang; Yi-Ping Mou; Hong-Jie Hu; Chao-Jie Huang; Guan-Yu Wang
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 7.  Overview of preventable industrial causes of occupational cancer.

Authors:  E Ward
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

8.  Clinical manifestations of primary hepatic angiosarcoma.

Authors:  Enrique Molina; Alfredo Hernandez
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Hepatic angiosarcoma manifested as recurrent hemoperitoneum.

Authors:  Seung-Woo Lee; Chun-Young Song; Young-Hwa Gi; Sang-Beom Kang; Yon-Soo Kim; Soon-Woo Nam; Dong-Soo Lee; Jong-Ok Kim
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 10.  Hepatic haemangiosarcoma in a patient with psoriasis and Crohn's disease.

Authors:  C J McCarthy; M Norton; C O'Morain
Journal:  Ir J Med Sci       Date:  1992-12       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.